English
MENUMENU

Nyheter

26 november, 2018

Allbright Foundation’s green list of Swedish companies promotes Immunovia for gender equality

A recent report published by the Allbright Foundation has shown that the gender balance in Swedish corporations is moving towards more equality, but large differences between companies still exist. Out of the 329 listed companies, 28 have female CEOs, 65% up since last year’s report. Furthermore, equality has advanced more when it comes to these […]

22 november, 2018

In a major drive to raise awareness about signs, symptoms and risk factors for pancreatic cancer, over 70 Boston-area primary care clinicians attended Immunovia´s educational symposium at Fenway Park, on World Pancreatic Cancer Day 2018

On November 15, 2018, Immunovia, Inc. sponsored an educational symposium at Fenway Park in honor of World Pancreatic Cancer Day, a day when people across the globe work together to increase awareness of the signs and symptoms of pancreatic cancer. Immunovia’s goal for the day was to increase awareness of the signs, symptoms and risk […]

15 november, 2018

Immunovia facility expansion

Today, on World Pancreatic Cancer Day November 15 2018, we are delighted to share with you some exciting news about Immunovia. The company is growing and is expanding its facility in Lund, Sweden. In preparation for commercialising IMMray™ PanCan-d for the early detection of pancreatic cancer, Immunovia has completed the expansion of its production and […]

12 oktober, 2018

Major Johns Hopkins study calls for new blood biomarker assays to improve pancreatic cancer survival rates in high risk individuals

An important new study by a group of researchers from John Hopkins  recently published in the peer-reviewed journal Gastroenterology has reinforced the importance of surveillance for individuals at high risk due to family history or genetic markers for pancreatic cancer.  In addition, the group called for better biomarker tests for early selection of patients for […]

16 juni, 2017

New Immunovia logotype

Immunovia reveals today the new logotype, one that can continue to grow and adapt with the development of the IMMray™ technology and its clinical applications in cancers and autoimmune diseases. This brand identity change is important for Immunovia for three reasons: -The company name is now easy to read and understand -New IMMray™ based tests […]

Prenumerera

Prenumerera på nyhetsbrev och rapporter via e-post.
För att starta din prenumeration behöver du aktivera den genom att klicka på länken i e-post meddelandet som blir skickat till dig efter att du klickat på Prenumerera i formuläret.

Pressmeddelanden
Finansiella rapporter